University of Münster
CRIS@UM
DE | EN

Dr. Darisuren Anhlan

Current affiliations

  • Institute of Molecular Virology

Publications

The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.
Schreiber A; Rodner F; Oberberg N; Anhlan D; Bletz S; Mellmann A; Planz O; Ludwig S (2024)
In: Antiviral Research, 225, 105840-105840. doi:10.1016/j.antiviral.2024.105840
Research article (journal) | Peer reviewed | Published
Cell-intrinsic genomic reassortment of pandemic H1N1 2009 and Eurasian avian-like swine influenza viruses results in potentially zoonotic variants.
Ferrando VA; Friedrich ME; Gandhi S; Mellmann A; Masemann D; Christersson A; Anhlan D; Brunotte L; Stoll M; Harder T; Beer M; Boergeling Y; Ludwig S (2023)
In: Emerging Microbes and Infections, 12(1), 2212809-2212809. doi:10.1080/22221751.2023.2212809
Research article (journal) | Peer reviewed | Published